With respect to exclusion and inclusion criteria, 632 out of 903 cases were included in this study. 55% (n = 350) were female and 45% (n = 282) were male patients. The mean age was 65.7 (± 12.1) years. Demographic data of patients can be seen in Table 1.
Table 1 Patients’ demographic data
According to WHO criteria, 0.5% (n = 3) were underweight, 29% (n = 181) were in normal range, 44% (n = 279) were overweight and 27% (n = 169) were obese.
59% (n = 371) of preoperative planning have been performed by consultant surgeons, 41% (n = 261) by residents in orthopaedic surgery.
74% (n = 469) of the used component designs were DePuy Synthes Inc. (Warsaw, IN, USA), whereas 26% (n = 163) were from Zimmer Inc. (Warsaw, IN, USA).
General reliability
The exact stem size was predicted in 42% (n = 264). Further, 45% (n = 283) were within a range of +/− one size. Thus, 87% (n = 547) of the stems have been measured accurately. Data of stem planning accuracy are presented in Table 2.
Table 2 Planning accuracy and deviation of implants in absolute values and percentage
37% (n = 231) of the cups were predicted correctly, whereas further 42% (n = 263) were within +/− one size. Altogether, cups were estimated correctly in 78% (n = 494). Data of cup planning accuracy are presented in Table 2.
Planner’s experience
Consultants predicted femoral component size correctly in 87.6% (n = 547) of the cases and residents in 85.1% (n = 325) of the cases. The difference between consultants and residents in predicting stem size within +/− one size was statistically significant (z = −2.11Footnote 1, p = 0.035).
Regarding cup size, differences in planning accuracy were not statistically significant (z = 0.64Footnote 2, p = 0.52).
BMI and planning accuracy
Regarding body weight, patients were split into four groups of BMI according to the WHO criteria: underweight, normal weight, overweight and obese. Underweight persons were ignored for calculation as this group consisted of three patients. The other groups have been analysed with Kruskal–Wallis test and paired post hoc tests.
Accurate stem size was predicted in 91.2% (n = 165) for normal weight, in 73.5% (n = 233) for overweight and in 87% (n = 147) for obese people. According to this, a high BMI leads to an inaccurate planning of femoral component size [H(2) = 6.05, p = 0.049]. Nevertheless, paired post hoc tests only documented a statistically significant difference of normal weight patients compared with overweight (p = 0.043), but not with obese, as expected.
Concerning cup size, 81.2% (n = 147) of normal weight patients, 77.4% (n = 216) of overweight and 76.9% (n = 130) of obese have been planned adequately. Post hoc calculations showed no statistically significance. Therefore, the impact of BMI on planning accuracy of the cup could not be approved [H(2) = 0.20, p = 0.901].
Component design
Stem components have been planned adequately in 85.3% (n = 402) in case of DePuy Corail, and in 89% (n = 145) in case of Zimmer Alloclassic. Cup size has been predicted correctly for DePuy Pinnacle in 79.3% (n = 372) and for Zimmer Allofit in 75.5% (n = 123). Mann–Whitney U test attested no statistically significant difference in planning accuracy regarding different implant designs (stem: z = − 1.1Footnote 3, p = 0.273; cup: z = − 0.23Footnote 4, p = 0.819).
Sex and planning accuracy
Femoral components have been planned correctly in 89.1% (n = 312) for female patients and in 83.3% (n = 235) for male patients. Cup planning has been adequate in 80.9% (n = 283) for females and in 75.2% (n = 212) for males. Analysing gender differences, Mann–Whitney U test showed no statistical significant difference, too (stem: z = 1.52Footnote 5, p = 0.13; cup: z = 1.87Footnote 6, p = 0.061).